Instrumento Inactivo

Acciones Ocata Therapeutics Inc OTC Bulletin Board

Acciones

Precio de cierre OTC Bulletin Board Otros sitios de cotización
- ^USD	-

Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	10/02/16
Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	22/01/16
Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	28/12/15
Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	03/12/15
OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	11/11/15

Directores	Puesto	Edad	Desde
Yoshitsuga Shitaka PSD	President	-	-
John Heffernan PRN	Corporate Officer/Principal	-	03/02/15

Administradores	Puesto	Edad	Desde
Percival Barretto-Ko BRD	Director/Board Member	51	-
Masaaki Hirano BRD	Director/Board Member	57	-
Toru Yoshimitsu BRD	Director/Board Member	61	-

Sector

	Varia. 1 de ene.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+7,52 %	113 mil M
REGENERON PHARMACEUTICALS, INC.	+11,38 %	106 mil M
BIONTECH SE	-12,64 %	22,22 mil M
ARGENX SE	+0,44 %	22,27 mil M
GENMAB A/S	-4,18 %	19,43 mil M
WUXI APPTEC CO., LTD.	-37,85 %	17,87 mil M
BEIGENE, LTD.	-8,58 %	17,24 mil M
SAREPTA THERAPEUTICS, INC.	+37,41 %	12,52 mil M
LEGEND BIOTECH CORPORATION	-23,95 %	8341,29 M